Market Closed -
Nasdaq Helsinki
11:29:54 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
19.2
EUR
|
+12.22%
|
|
+10.47%
|
+14.35%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,024
|
1,979
|
2,041
|
2,198
|
2,579
|
2,956
|
-
|
-
|
Enterprise Value (EV)
1 |
2,836
|
2,738
|
2,891
|
2,969
|
3,115
|
3,279
|
3,121
|
3,042
|
P/E ratio
|
18.4
x
|
15
x
|
19
x
|
9.55
x
|
13.1
x
|
11.6
x
|
13
x
|
12.1
x
|
Yield
|
4.22%
|
4.48%
|
4.35%
|
4.33%
|
4.05%
|
3.72%
|
3.82%
|
4.16%
|
Capitalization / Revenue
|
0.76
x
|
0.82
x
|
0.76
x
|
0.62
x
|
0.76
x
|
1.03
x
|
1.02
x
|
0.98
x
|
EV / Revenue
|
1.07
x
|
1.13
x
|
1.08
x
|
0.83
x
|
0.92
x
|
1.14
x
|
1.08
x
|
1.01
x
|
EV / EBITDA
|
6.92
x
|
6.29
x
|
6.79
x
|
5.19
x
|
4.67
x
|
5.98
x
|
5.91
x
|
5.52
x
|
EV / FCF
|
15.3
x
|
15.3
x
|
57.4
x
|
14.7
x
|
9.18
x
|
9.61
x
|
15.3
x
|
15.8
x
|
FCF Yield
|
6.53%
|
6.54%
|
1.74%
|
6.82%
|
10.9%
|
10.4%
|
6.55%
|
6.34%
|
Price to Book
|
1.66
x
|
1.66
x
|
1.54
x
|
1.32
x
|
1.55
x
|
1.78
x
|
1.6
x
|
1.49
x
|
Nbr of stocks (in thousands)
|
152,649
|
152,924
|
153,127
|
153,352
|
153,620
|
153,973
|
-
|
-
|
Reference price
2 |
13.26
|
12.94
|
13.33
|
14.33
|
16.79
|
19.20
|
19.20
|
19.20
|
Announcement Date
|
2/11/20
|
2/11/21
|
2/11/22
|
2/10/23
|
2/9/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
2,659
|
2,427
|
2,674
|
3,570
|
3,384
|
2,876
|
2,891
|
3,007
|
EBITDA
1 |
410
|
435.1
|
425.5
|
571.6
|
666.7
|
548.4
|
527.8
|
551.1
|
EBIT
1 |
224
|
237.7
|
225.4
|
361.6
|
463
|
381.2
|
338.8
|
364.1
|
Operating Margin
|
8.42%
|
9.79%
|
8.43%
|
10.13%
|
13.68%
|
13.26%
|
11.72%
|
12.11%
|
Earnings before Tax (EBT)
1 |
154.7
|
181
|
143.3
|
308.2
|
292
|
340.8
|
302.2
|
323.8
|
Net income
1 |
110.2
|
131.3
|
108.1
|
231.7
|
199.1
|
266.8
|
225.4
|
242.3
|
Net margin
|
4.14%
|
5.41%
|
4.04%
|
6.49%
|
5.88%
|
9.28%
|
7.8%
|
8.06%
|
EPS
2 |
0.7200
|
0.8600
|
0.7000
|
1.500
|
1.280
|
1.651
|
1.476
|
1.591
|
Free Cash Flow
1 |
185.2
|
179.1
|
50.4
|
202.4
|
339.2
|
341
|
204.2
|
193
|
FCF margin
|
6.97%
|
7.38%
|
1.88%
|
5.67%
|
10.02%
|
11.86%
|
7.07%
|
6.42%
|
FCF Conversion (EBITDA)
|
45.17%
|
41.16%
|
11.84%
|
35.41%
|
50.88%
|
62.18%
|
38.7%
|
35.02%
|
FCF Conversion (Net income)
|
168.06%
|
136.41%
|
46.62%
|
87.35%
|
170.37%
|
127.81%
|
90.63%
|
79.66%
|
Dividend per Share
2 |
0.5600
|
0.5800
|
0.5800
|
0.6200
|
0.6800
|
0.7150
|
0.7341
|
0.7991
|
Announcement Date
|
2/11/20
|
2/11/21
|
2/11/22
|
2/10/23
|
2/9/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
718.2
|
768.1
|
861.4
|
971.9
|
986.2
|
906
|
840.1
|
828.7
|
808.8
|
763.3
|
704.2
|
740.6
|
734.8
|
759
|
759
|
EBITDA
1 |
97.8
|
120
|
122.1
|
152.5
|
177
|
192.6
|
151
|
160.3
|
162.7
|
162.5
|
138
|
134
|
132.5
|
141
|
146
|
EBIT
1 |
47
|
68.9
|
69.7
|
99.5
|
123.4
|
141.9
|
100.9
|
107.6
|
112.6
|
117.6
|
95
|
79
|
89
|
93
|
98
|
Operating Margin
|
6.54%
|
8.97%
|
8.09%
|
10.24%
|
12.51%
|
15.66%
|
12.01%
|
12.98%
|
13.92%
|
15.41%
|
13.49%
|
10.67%
|
12.11%
|
12.25%
|
12.91%
|
Earnings before Tax (EBT)
1 |
8.7
|
54.4
|
60.2
|
77.1
|
116.5
|
122.7
|
85.1
|
94.6
|
-10.3
|
100.9
|
87
|
71
|
82
|
85
|
90
|
Net income
1 |
8.3
|
40.6
|
45
|
57.9
|
88.2
|
92.9
|
64.7
|
71.7
|
-30.2
|
75.8
|
68
|
56
|
64
|
65
|
69
|
Net margin
|
1.16%
|
5.29%
|
5.22%
|
5.96%
|
8.94%
|
10.25%
|
7.7%
|
8.65%
|
-3.73%
|
9.93%
|
9.66%
|
7.56%
|
8.71%
|
8.56%
|
9.09%
|
EPS
2 |
0.0500
|
0.2600
|
0.2900
|
0.3800
|
0.5700
|
0.6000
|
0.4200
|
0.4600
|
-0.2000
|
0.4900
|
0.4200
|
0.3400
|
0.4000
|
0.4000
|
0.4300
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0.6800
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/11/22
|
4/27/22
|
7/15/22
|
10/25/22
|
2/10/23
|
4/25/23
|
7/18/23
|
10/24/23
|
2/9/24
|
4/26/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
811
|
759
|
850
|
771
|
535
|
322
|
164
|
86.2
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.979
x
|
1.745
x
|
1.997
x
|
1.349
x
|
0.8029
x
|
0.5877
x
|
0.3113
x
|
0.1564
x
|
Free Cash Flow
1 |
185
|
179
|
50.4
|
202
|
339
|
341
|
204
|
193
|
ROE (net income / shareholders' equity)
|
9.2%
|
10.9%
|
12.1%
|
15.5%
|
17.4%
|
16%
|
13.1%
|
13.7%
|
ROA (Net income/ Total Assets)
|
3.9%
|
4.62%
|
-
|
6.82%
|
8.14%
|
7.7%
|
7.8%
|
8.3%
|
Assets
1 |
2,827
|
2,843
|
-
|
3,395
|
2,445
|
3,465
|
2,889
|
2,919
|
Book Value Per Share
2 |
7.980
|
7.800
|
8.680
|
10.90
|
10.80
|
10.80
|
12.00
|
12.90
|
Cash Flow per Share
2 |
2.530
|
2.440
|
1.440
|
2.610
|
3.560
|
2.900
|
2.700
|
2.700
|
Capex
1 |
201
|
196
|
170
|
198
|
207
|
105
|
201
|
199
|
Capex / Sales
|
7.56%
|
8.06%
|
6.35%
|
5.54%
|
6.11%
|
3.65%
|
6.94%
|
6.62%
|
Announcement Date
|
2/11/20
|
2/11/21
|
2/11/22
|
2/10/23
|
2/9/24
|
-
|
-
|
-
|
Last Close Price
19.2
EUR Average target price
19.7
EUR Spread / Average Target +2.60% Consensus |
1st Jan change
|
Capi.
|
---|
| +14.35% | 3.16B | | -0.19% | 74.89B | | +0.09% | 46.52B | | -4.19% | 30.82B | | +9.85% | 18.19B | | -10.05% | 11.54B | | +6.39% | 11.24B | | -8.09% | 9.73B | | +2.79% | 9.4B | | +6.35% | 9.37B |
Diversified Chemicals
|